Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. Financials
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/07 08:33:48 am
268.97 USD   +1.37%
07:45aMarketScreener's World Press Review - December 7, 2021
07:16aEU agencies endorse mix-and-match of COVID-19 vaccines
RE
06:46aREFILE-EU health bodies recommend mix-and-match of COVID-19 vaccines
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 5 0236 51841 340107 578--
Entreprise Value (EV)1 4 3985 54836 84295 23483 57676 230
P/E ratio -12,5x-12,6x-53,3x10,1x10,2x21,0x
Yield ------
Capitalization / Revenue 37,2x108x51,5x6,15x5,25x8,50x
EV / Revenue 32,6x92,1x45,9x5,44x4,08x6,02x
EV / EBITDA -11,3x-10,8x-50,3x7,77x6,02x13,4x
Price to Book -6,14x16,3x7,02x3,71x2,82x
Nbr of stocks (in thousands) 328 948333 250395 710405 450--
Reference price (USD) 15,319,6104265265265
Announcement Date 03/06/201902/26/202002/25/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 13560,280317 50520 49412 654
EBITDA1 -388-515-73212 25213 8815 697
Operating profit (EBIT)1 -413-546-76312 22313 8387 569
Operating Margin -306%-906%-95,0%69,8%67,5%59,8%
Pre-Tax Profit (EBT)1 -384-515-74512 34913 4017 700
Net income1 -402-514-74711 21711 0136 058
Net margin -298%-854%-93,0%64,1%53,7%47,9%
EPS2 -1,22-1,55-1,9626,425,912,6
Dividend per Share2 ------
Announcement Date 03/06/201902/26/202002/25/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 1 9374 3544 9695 9796 8285 959
EBITDA ------
Operating profit (EBIT)1 1 2663 0623 5584 1744 7794 001
Operating Margin 65,4%70,3%71,6%69,8%70,0%67,1%
Pre-Tax Profit (EBT)1 1 2603 0633 5524 4234 1303 154
Net income1 1 2212 7803 3333 7683 4002 603
Net margin 63,0%63,8%67,1%63,0%49,8%43,7%
EPS2 2,846,467,708,607,775,91
Dividend per Share ------
Announcement Date 05/06/202108/05/202111/04/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 6259714 49812 34424 00231 348
Leverage (Debt / EBITDA) 1,61x1,89x6,15x-1,01x-1,73x-5,50x
Free Cash Flow1 -437-4911 96010 1979 4666 865
ROE (Net Profit / Equities) -39,3%-38,0%-40,0%120%54,1%22,1%
Shareholders' equity1 1 0231 3531 8689 38620 37127 358
ROA (Net Profit / Asset) -25,3%-28,9%-16,7%74,5%41,4%15,7%
Assets1 1 5911 7764 46315 05826 58538 548
Book Value Per Share2 -3,196,4237,871,694,0
Cash Flow per Share2 -1,01-5,3238,831,310,8
Capex1 10631,667,4359395258
Capex / Sales 78,3%52,4%8,40%2,05%1,93%2,04%
Announcement Date 03/06/201902/26/202002/25/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 107 577 922 998
Net sales (USD) 803 395 000
Number of employees 1 300
Sales / Employee (USD) 617 996
Free-Float 90,5%
Free-Float capitalization (USD) 97 322 936 806
Avg. Exchange 20 sessions (USD) 3 741 007 719
Average Daily Capital Traded 3,48%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA